Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisy Chen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Research Square|October 14, 2024
Plasmodium SEY1 is a novel druggable target that contributes to imidazolopiperazine mechanism of actionElizabeth Winzeler, Krypton Carolino, Mariana Laureano De Souza, et al.
Diabetes Care|July 24, 2025
Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover StudyClara Mosquera-Lopez, Valentina Roquemen-Echeverri, Peter G Jacobs, et al.
Cell Chemical Biology|October 8, 2025
Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitorsSelina Bopp, Lọla Fagbami, Amy Deik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2025
Fungal-derived methyldeoxaphomins target <i>Plasmodium falciparum</i> segregation through the inhibition of PfActin1Tiantian Jiang, Jin Woo Lee, Jennifer E Collins, et al.
Mbio|November 24, 2025
Mechanistic insights into dual-active liver and blood-stage antiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Mechanistic Insights into Dual-Active Liver and Blood-Stage AntiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Nature|May 21, 2025
In vivo screen of Plasmodium targets for mosquito-based malaria controlAlexandra S Probst, Douglas G Paton, Federico Appetecchia, et al.
Cell Chemical Biology|July 8, 2025
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activityFlore Nardella, Tiantian Jiang, Lushun Wang, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Science (New York, N.Y.)|November 28, 2024
Systematic in vitro evolution in <i>Plasmodium falciparum</i> reveals key determinants of drug resistanceMadeline R Luth, Karla P Godinez-Macias, Daisy Chen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Research Square|October 14, 2024
Plasmodium SEY1 is a novel druggable target that contributes to imidazolopiperazine mechanism of actionElizabeth Winzeler, Krypton Carolino, Mariana Laureano De Souza, et al.
Diabetes Care|July 24, 2025
Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover StudyClara Mosquera-Lopez, Valentina Roquemen-Echeverri, Peter G Jacobs, et al.
Cell Chemical Biology|October 8, 2025
Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitorsSelina Bopp, Lọla Fagbami, Amy Deik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2025
Fungal-derived methyldeoxaphomins target <i>Plasmodium falciparum</i> segregation through the inhibition of PfActin1Tiantian Jiang, Jin Woo Lee, Jennifer E Collins, et al.
Mbio|November 24, 2025
Mechanistic insights into dual-active liver and blood-stage antiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Mechanistic Insights into Dual-Active Liver and Blood-Stage AntiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Nature|May 21, 2025
In vivo screen of Plasmodium targets for mosquito-based malaria controlAlexandra S Probst, Douglas G Paton, Federico Appetecchia, et al.
Cell Chemical Biology|July 8, 2025
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activityFlore Nardella, Tiantian Jiang, Lushun Wang, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Science (New York, N.Y.)|November 28, 2024
Systematic in vitro evolution in <i>Plasmodium falciparum</i> reveals key determinants of drug resistanceMadeline R Luth, Karla P Godinez-Macias, Daisy Chen, et al.
Pageof 3